LATEST

Off the Wire

IN FOCUS

The Growing Role of Advanced PET Imaging in Breast Cancer Care

Positron Emission Tomography (PET) is becoming an increasingly important tool in managing breast cancer. This shift is largely due to more PET radiotracers being approved by the...

Nanotechnology-Enhanced Resveratrol Shows Promise in Treatment of Triple-Negative Breast Cancer

Yes, it's that kind of resveratrol--that found in red wine. But with a technical twist to ensure it's delivered properly. Triple-negative breast cancer (TNBC) is a type of...

What a Massive Study of 12 Million Says About Breast Cancer Screening, Rates

A recent study, remarkable for its sheer sample size, sheds light on the escalating issue of breast cancer among women in China, highlighting a noticeable uptick in...

LEARN MORE

RESEARCH

RESEARCH

LEARN MORE

New Research Shines Light on Hormone Therapy Resistance in Breast Cancer

Recent advancements in the research of hormone therapy resistance in advanced estrogen receptor (ER) positive breast cancers has revealed important considerations for future treatment. A...

Atossa Therapeutics Hits Milestone in Breast Cancer Trial with Full Enrollment

Atossa Therapeutics Inc has recently made an announcement about progress in one of its breast cancer studies. They've completed enrolling participants for a specific...

BriaCell Reveals Notable Results in Breast Cancer Treatment Trials

BriaCell Therapeutics Corp., a biotech firm focused on developing new treatments for cancer, recently shared promising results from their studies on breast cancer treatments....

Elacestrant Unveiled: A New Horizon for Hormone-Driven Breast Cancer

Patients with a type of breast cancer that grows in response to estrogen (ER-positive) but does not have the HER2 protein (HER2-negative) often start...

BCI Test Predicts Breast Cancer Recurrence Risk in Hormone Therapy Patients

The Breast Cancer Index (BCI) has been validated as a tool for predicting the risk of breast cancer recurrence in postmenopausal women treated with...

DRUG DEVELOPMENT